Treatment of Hodgkin Lymphoma Relapsed after Autologous Stem Cell Transplantation

Although autologous stem cell transplantation (auto-HCT) is the standard of care for patients with refractory/relapsed (R/R) classical Hodgkin’s lymphoma (cHL), there is still a significant proportion of patients that relapse after the procedure. This review contemplates different treatment strategi...

Descripción completa

Detalles Bibliográficos
Autores principales: Domingo-Domènech, Eva, Sureda, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290321/
https://www.ncbi.nlm.nih.gov/pubmed/32397141
http://dx.doi.org/10.3390/jcm9051384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290321/
https://www.ncbi.nlm.nih.gov/pubmed/32397141
http://dx.doi.org/10.3390/jcm9051384

Ejemplares similares